Evidence-Based Medicine

Print Friendly
TeaReljic

Tea Reljic, MPH

Statistical Data Analyst, College Of Medicine Internal Medicine

Contact Info 3515 E. Fletcher Ave
Tampa, FL 33612

Academic Email: treljic@health.usf.edu

Academic Phone: (813) 974-7806

Education

  • MPH, Epidemiology and Biostatistics, University of South Florida, 2013
  • BS, Microbiology, University of Texas, 2008

Recent Publications

  • Reljic T, Mahony H, Djulbegovic B, Etchason J, Paxton H, Flores M, Kumar A Value of repeat head computed tomography after traumatic brain injury: systematic review and meta-analysis J Neurotrauma. 31(1) : 78-98, 2014.
  • Mhaskar RS, Reljic T, Wao H, Kumar A, Miladinovic B, Djulbegovic B Treatment-related harms: What was planned and what was reported? National Cancer Institute's Co-operative group phase III randomized controlled trials: a systematic review J Clin Elopemiol. 67(3) : 354-6, 2014.
  • El-Jurdi N, Reljic T, Kumar A, Pidala J, Bazarbachi A, Djulbegovic B, Kharfan-Dabaja MA Efficacy of adoptive immunotherapy with donor lymphocyte infusion in relapsed lymphoid malignancies: a systematic review/meta-analysis Immunotherapy. 5(5) : 457-66, 2013.
  • Kharfan-Dabaja MA, Hamadani M, Reljic T, Nishihori T, Bensinger W, Djulbegovic B, Kumar A Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials J Hematol Oncol. 6: 2, 2013.
  • Duong VH, Lin K, Reljic T, Kumar A, Al Ali NH, Lancet JE, List AF, Komrokji RS Poor outcome of patients with myelodysplastic syndrome after azacitidine treatment failure Clin Lymphoma Myeloma Leuk. 13(6) : 711-5, 2013.
  • Kharfan-Dabaja MA, Hamadani M, Reljic T, Pyngolil R, Komrokji RS, Lancet JE, Fernandez HF, Djulbegovic B, Kumar A Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis Br J Haematol. 163(3) : 315-25, 2013.
  • Djulbegovic B, Kumar A, Miladinovic B, Reljic T, Galeb S, Mhaskar A, Mhaskar R, Hozo I, Tu D, Stanton HA, Booth CM, Meyer RM Treatment Success in Cancer: Industry Compared to Publicly Sponsored Randomized Controlled Trials PLoS ONE. 8(3) : e58711, 2013.
  • Kumar A, Mhaskar AR, Reljic T, Mhaskar RS, Kharfan-Dabaja MA, Anasetti C, Mohty M, Djulbegovic B Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review Leukemia. 26(4) : 582-8, 2012.
  • Djulbegovic B, Kumar A, Glasziou PP, Perera R, Reljic T, Dent L, Raftery J, Johansen M, Di Tanna GL, Miladinovic B, Soares HP, Vist GE, Chalmers I New treatments compared to established treatments in randomized trials Cochrane Database Syst Rev. (10) , 2012.